Considerations for Sterile Compounding of Parenteral Products for Pediatric Use: Part 2 PharMEDium Lunch and Learn Series LUNCH AND LEARN
|
|
- Dinah Fisher
- 5 years ago
- Views:
Transcription
1 LUNCH AND LEARN Considerations for Sterile Compounding of Parenteral Products for Pediatric Use: Part 2 November 10, 2017 Featured Speaker: Kirsten H. Ohler, PharmD, BCPS, BCPPS Neonatal / Pediatric Clinical Pharmacist Clinical Associate Professor, Pharmacy Practice Program Director, PGY2 Pediatric Pharmacy Residency University of Illinois at Chicago College of Pharmacy CE Activity Information & Accreditation (Pharmacist and Tech CE) 1.0 contact hour Funding: This activity is self funded through PharMEDium. It is the policy of to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Dr. Ohler has no relevant commercial and/or financial relationships to disclose
2 Online Evaluation, Self-Assessment and CE Credit Submission of an online self assessment and evaluation is the only way to obtain CE credit for this webinar Go to Print your CE Statement online Live CE Deadline: December 8, 2017 CPE Monitor CE information automatically uploaded to NABP/CPE Monitor upon completion of the self assessment and evaluation (user must complete the claim credit step) Attendance Code Code will be provided at the end of today s activity Attendance Code not needed for On Demand 3 Ask a Question Submit your questions to your site manager. Questions will be answered at the end of the presentation. Your question...? 4 2
3 Resources Visit to access: Handouts Activity information Upcoming live webinar dates Links to receive CE credit 5 Considerations for Sterile Compounding of Parenteral Products for Pediatric Use: Part 2 Kirsten H. Ohler, PharmD, BCPS, BCPPS Clinical Associate Professor, Pharmacy Practice Clinical Pharmacy Specialist, NICU University of Illinois at Chicago 6 3
4 Disclosure The speaker, Kirsten H. Ohler, has no actual or potential conflicts of interest related to the information included in this presentation. The practice of off label medication use in pediatric patients will be discussed. 7 Objectives At the conclusion of Part 2, participants will be able to: 1. Identify considerations in drug formulation and drug delivery processes specific to the pediatric population. 2. Discuss medication safety issues specific to the pediatric population and potential methods to address them. 3. Describe the role a compounding pharmacy team can have in the care of pediatric patients
5 Drug Delivery Process Considerations Availability of a pediatric friendly formulation Need for multiple concentrations Need to make dilutions for measurable volumes Availability of appropriate drug delivery device Measurable rates Pediatric specific safety features Impact of dead space in syringe Impact of priming volume in tubing In line filters may adsorb drugs Risk of catheter occlusion 9 Considerations Drug Delivery Process Methods to manage solution overfill Simple admixture may be used if entire bag to be infused to single patient Withdrawal drug volume may be used if volume of medication to be added is large Withdrawal drug & overfill volume may be used if volume of medication to be added is large Empty container may be used when final concentration of drug must be precise Must have defined process with clear labeling
6 Drug Delivery Process Methods of intravenous administration IV push (IVP) Check compatibility Physiologic effects of rapid administration Example: Sodium bicarbonate & intraventricular hemorrhage Dead space Area between the syringe hub and needle» ~0.05mL for a 1mL syringe Example: Digoxin 100 mcg/ml» 0.5kg x 5 mcg/kg/day = 2.5 mcg/day = 1.25 mcg every 12 hr» 1.25 mcg = ml using 100 mcg/ml» 1.25 mcg = ml using 10 mcg/ml dilution 0.05 ml dead space = 40% increase in volume/dose 11 Drug Delivery Process Methods of intravenous administration IV piggyback (IVPB) / intermittent infusion Check compatibility with fluids and other drugs Fluid considerations: Mini bag vs. syringe Typical mini bag volume ml Example: 0.5 kg, total daily fluid requirement = 120 ml/kg/day = 60 ml/day including TPN, feedings, medications Priming volume of tubing
7 Drug Delivery Process Methods of intravenous administration Continuous IV infusion Check compatibility with fluids and other drugs Variability in dosing units (e.g., ml/hr, mcg/kg/hr, mg/hr) Measurable rates Example: Dopamine 0.55 kg x 5 mcg/kg/min = 0.1 ml/hr using 1600 mcg/ml 0.55 kg x 5 mcg/kg/min = 0.2 ml/hr using 800 mcg/ml 0.55 kg x 1 mcg/kg/min = 0.04 ml/hr using 800 mcg/ml Considerations for priming tubing 13 Drug Delivery Devices Buretrol Holding chamber between IV bag and infusion pump Safety mechanism to prevent accidental large fluid bolus Medications can be added to chamber Low IV flow rate affects drug delivery Not routinely used
8 Drug Delivery Devices Syringe Pump 15 Drug Delivery Devices Syringe Pump May be used for intermittent doses or continuous infusion Considerations Minimum / Maximum syringe sizes Minimum rate Usually 0.1 ml/hr Minimum rate change Usually at least 2 decimal places (e.g., 0.01 ml/hr) Microbore tubing Typically small priming volume (~1 ml) May not have smart pump features
9 Drug Delivery Devices Large Volume IV Pumps 17 Drug Delivery Devices Large Volume IV Pumps May be used for IVPB or continuous infusion Considerations Minimum rate Depends on pump, usually 0.1 ml/hr or 1 ml/hr Minimum rate change Usually only 1 decimal place (e.g., 0.1 ml/hr) Large bore tubing Typical priming volume: ml May not have smart pump features
10 Definition Medication Error Preventable event Result of system flaw or human error Occurs during ordering, preparation, administration Harm or potential harm does not have to be present Near miss Error caught before it reached the patient 19 Medication Error What s the Risk? Pediatric Medication Orders 15% Pediatric Medication Errors 31% Error No Error Harm/Death No Harm Crowley E, et al. Curr Ther Res
11 Inaccurate transcription Miscommunication Improper documentation Drug distribution system Knowledge deficit Calculation error Procedure/Protocol not followed Performance Deficit Medication Errors Computer entry error Lack of system safeguards 21 Why are Children at Higher Risk? Minimal information in the PharmD curriculum Developmental pharmacokinetics Off label medication use Metric confusion Grams vs. Kilograms vs. Pounds Prescott WA, et al. AJPE
12 Why are Children at Higher Risk? Weight based dosing mg/kg/dose vs. mg/kg/day mcg/kg/min vs. mcg/kg/hour Body weight vs. body surface area Adult dose 23 Why are Children at Higher Risk? Growth / weight gain necessitates dose recalculations Lack of dose adjustment can result in subtherapeutic effect Need for multiple concentrations / lack of standardized concentrations Less physiologic reserve than adults
13 Methods for Decreasing Errors In general Avoid abbreviations Drug names (e.g., MSO4) Units of measure (e.g., U) Instructions (e.g., QD) Always include a leading zero (e.g., 0.5 mg), never a trailing zero (e.g., 5.0 mg) 25 Methods for Decreasing Errors Utilize pharmacist consultation Preparation of medications by pharmacy staff rather than nursing staff Integrate pharmacists into patient care rounds >80% reduction in error rate Pharmacy staff should be adequately trained to care for children Provide ongoing educational system for staff Offer pediatric specific formulary with criteria for evaluation, selection, use AAP. Pediatrics Fortescue EB, et al. Pediatrics
14 Methods for Decreasing Errors Standardize units of weight (i.e. kg vs. pounds) Standardize concentrations For continuous, intermittent, and IVP medications Eliminate rule of 6 calculations for continuous infusions Example: 6 x weight (kg) = amount of drug (mg) 100 ml of solution Then 1 ml/hr = 1 mcg/kg/min ASHP Standardize 4 Safety initiative Institute for Safe Medication Practices (ISMP) standard concentrations for neonatal infusions AAP. Pediatrics Methods for Decreasing Errors Computerized prescriber order entry (CPOE) Needs to be pediatric specific Dose range checking Renal dosing alerts Clinical decision support features May prevent some errors and create others Beware of alert fatigue Not all CPOE systems have the same capabilities AAP. Pediatrics
15 Methods for Decreasing Errors Utilize technology during compounding Bar code scan Specific gravity / product weight measurement Comprehensive labeling of final product Drug name and dose Base solution Final volume Final concentration Standardize equipment (e.g., infusion pumps) Utilize double checks Rich DS, et al. Hosp Pharm Methods for Decreasing Errors Bedside bar code scanning Beware of work arounds Utilize smart pump technology Must utilize pediatric specific information Weight range limits Pressure limits Drug library Pre programmed concentrations Dose range limits Automated calculations AAP. Pediatrics
16 Smart Pump Technology Standard concentration Specific library Rate calculation automated Weight & Dose are entered manually 31 Methods for Decreasing Errors Clear communication Error tracking system Include all errors regardless of severity / potential for harm Voluntary reporting typically underestimates true error rates System flaws vs. individual fault Eliminate barriers to reporting errors Just culture AAP. Pediatrics
17 Role of the Pharmacy Team Promote a culture of safety Utilize technology Insure use of standard concentrations Conduct research on stability / compatibility Pursue additional pediatric specific education PGY2 pediatric residency training Board certified pediatric pharmacy specialist (BCPPS) 33 Conclusions Children are a vulnerable population Medication errors occur more frequently and with greater severity in children Awareness of unique safety concerns is imperative for identifying preventative strategies throughout the drug delivery process Get pediatric smart and practice in a just culture
18 References American Academy of Pediatrics, Committee on Drugs and Committee on Hospital Care. Policy statement: Prevention of medication errors in the pediatric inpatient setting. Pediatrics. 2003;112: American Academy of Pediatrics, Steering Committee on Quality Improvement and Management and Committee on Hospital Care. Policy statement: Principles of pediatric patient safety: reducing harm due to medical care. Pediatrics. 2011;127: Crowley E, Williams R, Cousins D. Medication errors in children: a descriptive summary of medication error reports submitted to the United States Pharmacopeia. Curr Ther Res. 2001;26: Fortescue EB, Kaushal R, Landrigan CP, et al. Prioritizing strategies for preventing medication errors and adverse drug events in pediatric inpatients. Pediatrics. 2003;111: Grissinger M. Understanding and managing intravenous container overfill. P & T. 2016;41:140 1 & 172. Levine SR, Cohen MR, Blanchard N, et al. Guidelines for preventing medication errors in pediatrics. J Pediatr Pharmacol Ther. 2001;6: Prescott WA, Dahl EM, Hutchinson DJ. Education in pediatrics in US colleges and schools of pharmacy. AJPE. 2014;78:1 9. Rich DS, Fricker Jr. MP, Cohen MR, et al. Guidelines for the safe preparation of sterile compounds: results of the ISMP sterile preparation compounding safety summit of October Hosp Pharm. 2013;48: Sherwin CMT, Medlicott NJ, Reith DM, et al. Intravenous drug delivery in neonates: lessons learnt. Arch Dis Child. 2014;99:
Session Objectives. Medication Errors in Adults and Children. Dennis Quaid American Society of Health- System Pharmacists (ASHP) Meeting December 2009
Medication Errors in Adults and Children Carly C. Feldott, PharmD Medication Safety Program Director, VUMC Amy L. Potts, PharmD, BCPS Assistant Director, Monroe Carell, Jr. Children s Hospital at Vanderbilt
More informationMedication Safety Technology The Good, the Bad and the Unintended Consequences
Medication Safety Technology The Good, the Bad and the Unintended Consequences Michelle Mandrack RN, MSN Director of Consulting Services Matthew Fricker, RPh, MS Program Director 1 Objectives Consider
More informationMedication Safety Issues and Recommended Strategies Related to Sterile Compounding PharMEDium Lunch and Learn Series LUNCH AND LEARN
LUNCH AND LEARN Medication Safety Issues and Recommended Strategies Related to Sterile Compounding January 12, 2018 Featured Speaker: Christina Michalek, BS, RPh, FASHP Medication Safety Specialist Institute
More informationSHRI GURU RAM RAI INSTITUTE OF TECHNOLOGY AND SCIENCE MEDICATION ERRORS
MEDICATION ERRORS Patients depend on health systems and health professionals to help them stay healthy. As a result, frequently patients receive drug therapy with the belief that these medications will
More informationInfusion Pumps: The Delivery Mechanism For Your Compounded Products PharMEDium Lunch and Learn Series
LUNCH AND LEARN Infusion Pumps: The Delivery Mechanism For Your Compounded Products June 13, 2014 Featured Speaker: Seth Eisenberg, RN, ASN, OCN, BMTCN Professional Practice Coordinator, Infusion Services
More informationOHTAC Recommendation. Implementation and Use of Smart Medication Delivery Systems
OHTAC Recommendation Implementation and Use of Smart Medication Delivery Systems July 2009 Background The Ontario Health Technology Advisory Committee (OHTAC) engaged the University Health Network s (UHN)
More informationMedication Safety & Electrolyte Administration. Objectives. High Alert Medications. *Med Safety Electrolyte Administration
Medication Safety & Electrolyte Administration Jennifer Doughty, PharmD PGY2 Pharmacy Resident Emergency Medicine Stormont Vail Health, Topeka, KS Objectives Define and identify high alert medications
More informationImproving the Safe Use of Multiple IV Infusions
QUICK GUIDE Improving the Safe Use of Multiple IV Infusions The AAMI Foundation is grateful to its collaborating partners in the National Coalition for Infusion Therapy Safety: Acknowledgements The AAMI
More informationREVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY
REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version. Overarching and Governance Statements 1. The overarching
More informationCanadian Paediatric High Alert Medication Delivery
Canadian Paediatric High Alert Medication Delivery Paediatric Opioid Safety - Phase 3: Education, Knowledge Translation and Implementation Final Report January 16, 2013 Respectfully Submitted by Elaine
More informationCHALLENGE OF NURS 205 (DRUG DOSAGE CALCULATION) AND/OR NURS 212 (PHARMACOLOGY FOR NURSES) BY EXAM
CONTRA COSTA COLLEGE LAVA DIVISION ASSOCIATE DEGREE NURSING PROGRAM CHALLENGE OF NURS 205 (DRUG DOSAGE CALCULATION) AND/OR NURS 212 (PHARMACOLOGY FOR NURSES) BY EXAM POLICY: A nursing applicant who has
More informationObjectives MEDICATION SAFETY & TECHNOLOGY. Disclosure. How has technology improved the way we dispense and compound medications AdminRx AcuDose Rx
MEDICATION SAFETY & TECHNOLOGY Objectives Identify technology that can improve medication safety and decrease medication errors Identify ways that technology can cause medication errors if used inappropriately
More informationAseptic Processing Assessments
Assessments Introduction This training can be used towards a number of accredited awards and in house training NVQ Pharmacy Services see competency mapping City and Guilds Process Technology Special processes
More informationMedication Math Homework Part 1. Part A. Convert the following patient weights from pounds to kilograms lbs lbs. 6.
Medication Math Homework Part 1 Part A. Convert the following patient weights from pounds to kilograms 1. 22 lbs 4. 150 lbs 7. 250 lbs 2. 80 lbs 5. 180 lbs 8. 300 lbs 3. 100 6. 200 lbs 9. 35 lbs Part B.
More informationPlum 360 TM Infusion System with Full IV-EHR Interoperability
Plum 360 TM Infusion System with Full IV-EHR Interoperability Your Direct Connection To Clinical Excellence > Air management that doesn t require disconnecting from the patient > A secondary line that
More informationPolicy Statement Medication Order Legibility Medication orders will be written in a manner that provides a clearly legible prescription.
POLICY POLICY PURPOSE: The purpose of this policy is to provide a foundation for safe communication of medication and nutritional orders in-scope, thereby reducing the potential for preventable medication
More informationClinical Skills Validation: Alaris Pump System
Clinical Skills Validation: Alaris Pump System These documents are intended for use by CW Nurse Clinical Leadership Team. The method used to implement the validation of the Alaris Pump System is unit specific.
More informationASHP-PPAG Guidelines for Providing Pediatric Pharmacy Services in Hospitals and Health Systems. Purpose Elements of Care...
Hospitals and Health Systems Purpose... 6 Elements of Care... 6 Standard I. Practice Management... 7 A. Pharmacy and Pharmacist Services... 7 Pharmacy mission, goals, and scope of services.... 7 Hours
More information9/29/2014. Disclosure: I, Amber Sanders have no financial relationship to disclose. Objectives. Medication Safety in Pediatric Populations
Medication Safety in Pediatric Populations By: Amber Sanders Disclosure: I, Amber Sanders have no financial relationship to disclose Objectives Identify Pediatric Medication Safety Guidelines Institute
More informationAdministration of Medication IV Push to Neonatal/Paediatric & Adult Patients Self-Learning Package
Administration of Medication IV Push to Neonatal/Paediatric & Adult Patients Self-Learning Package Prepared by Cheryl Owen, CPL Medicine, Rose Owen CPL NICU/SCN; Jan. 2008 Revised by Rose Owen CPL NICU/SCN;
More informationImproving Sterile Compounding: Impact of New Regulations, Standards and Guidelines PharMEDium Lunch and Learn Series LUNCH AND LEARN
LUNCH AND LEARN Improving Sterile Compounding: Impact of New Regulations, Standards and Guidelines September 9, 2016 Featured Speaker: Darryl S. Rich, PharmD, MBA, FASHP Medication Safety Specialist Institute
More informationNATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas
NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT Safer Use of Injectable Medicines In Near-Patient Areas Wide Stake Holder Consultation January March 2006 The NPSA is undertaking a wide stake
More informationWYOMING STATE BOARD OF NURSING ADVISORY OPINION
WYOMING STATE BOARD OF NURSING ADVISORY OPINION INTRAVENOUS THERAPY BY LICENSED PRACTICAL NURSES Advisory Opinion Number: 03-123 Board Meeting Date: April 28-May 1, 2003 January 7-10, 2008 Introduction:
More informationObjectives. Demographics: Type and Services 1/22/2014. ICAHN Aggregate Results. ISMP Medication Safety Self Assessment for Hospitals
ICAHN Aggregate Results ISMP Medication Safety Self Assessment for Hospitals Matthew Fricker, RPH, MS, FASHP Rebecca Lamis, PharmD, FISMP January 23, 2014 1 Objectives Report the demographic characteristics
More informationOne or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration
One or More Errors in 67% of the IV Infusions: Insights from a Study of IV Medication Administration Presented by: Marla Husch Northwestern Memorial Hospital Northwestern Memorial Hospital Chicago, Illinois
More informationAlaris Products. Protecting patients at the point of care
Alaris Products Protecting patients at the point of care Overview The medication process is the largest source of medical errors 1 with medication errors costing an estimated $3.5 billion yearly in hospitals.
More informationUniversity of Mississippi Medical Center University of Mississippi Health Care. Pharmacy and Therapeutics Committee Medication Use Evaluation
University of Mississippi Medical Center University of Mississippi Health Care Pharmacy and Therapeutics Committee Medication Use Evaluation TJC Standards for Medication Management March 2012 Purpose The
More informationExample of a Health Care Failure Mode and Effects Analysis for IV Patient Controlled Analgesia (PCA) Failure Modes (what might happen)
Prescribing Assess patient Choose analgesic/mode of delivery Prescribe analgesic Institute for Safe Medication Practices Example of a Health Care and Effects Analysis for IV Patient Controlled Analgesia
More informationMaryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center
Maryland Patient Safety Center s Annual MEDSAFE Conference: Taking Charge of Your Medication Safety Challenges November 3, 2011 The Conference Center at the Maritime Institute Improving Staff Education
More informationObjectives. Key Elements. ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management 5/20/2014
ICAHN Targeted Focus Areas: Staff Competency and Education Quality Processes and Risk Management Matthew Fricker, RPh, MS, FASHP Program Director, ISMP Rebecca Lamis, PharmD, FISMP Medication Safety Analyst,
More informationMedication Safety Way Beyond the 5 Rights
Safety Way Beyond the 5 Rights JoAnne Phillips, MSN, RN, CCRN, CCNS, CPPS The University of Pennsylvania Health System Philadelphia, PA Current State. Of Chaos Prescriptions 12 per /person / year 4 BILLION
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationProfiles in CSP Insourcing: Tufts Medical Center
Profiles in CSP Insourcing: Tufts Medical Center Melissa A. Ortega, Pharm.D., M.S. Director, Pediatrics and Inpatient Pharmacy Operations Tufts Medical Center Hospital Profile Tufts Medical Center (TMC)
More informationCurrent Status: Active PolicyStat ID:
Current Status: Active PolicyStat ID: 2002682 Origination: 05/2005 Last Approved: 02/2014 Last Revised: 02/2014 Next Review: 01/2017 Owner: Policy Area: References: Chase Walters: Director, Education Patient
More informationReducing the risk of serious medication errors in community pharmacy practice
Reducing the risk of serious medication errors in community pharmacy practice Eastern Medicaid Pharmacy Administrators Association (EMPAA) November 1, 2017 Newport, Rhode Island Michael R. Cohen, RPh,
More informationPURPOSE To establish a standardized process for the activity of an independent double check for medication administration.
PURPOSE To establish a standardized process for the activity of an independent double check for medication administration. POLICY STATEMENTS Health Care Providers will complete the independent double check
More informationAdverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN
Adverse Drug Events: A Focus on Anticoagulation Steve Meisel, Pharm.D., CPPS Director of Patient Safety Fairview Health Services, Minneapolis, MN Fairview Health Services 6 hospitals, ranging from rural
More informationSafe Medication Practices
Safe Medication Practices Patient Safety: Preventing Adverse Events OHA Conference Renaissance Toronto Hotel at SkyDome Toronto June 14, 2004 David U President & CEO, ISMP Canada Agenda ISMP Canada Patient
More informationStrands & Standards PHARMACY TECHNICIAN
Strands & Standards PHARMACY TECHNICIAN COURSE DESCRIPTION An instructional program that prepares individuals to support pharmacists. This includes pharmacist approved consultation regarding Over-the-Counter
More informationMedication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016
Medication Errors in Chemotherapy PORSCHA L. JOHNSON, PHARM.D. CLINICAL PHARMACIST II MEDSTAR WASHINGTON HOSPITAL CENTER SATURDAY, SEPTEMBER 17, 2016 DISCLOSURE STATEMENT I have nothing to disclose regarding
More informationMEDICATION ADMINISTRATION: BELOW THE DRIP CHAMBER
KINGSTON GENERAL HOSPITAL MEDICATION ADMINISTRATION: BELOW THE DRIP CHAMBER LEARNING GUIDE FOR REGISTERED NURSES AND REGISTERED PRACTICAL NURSES Prepared by: Nursing Education Date: 2001 November Revised:
More informationPHARMACY PRACTICE. Residency Program
PHARMACY PRACTICE Residency Program PGY-1 Pharmacy Practice RESIDENCY OVERVIEW The Pharmacy Practice Residency Program is a comprehensive post-graduate training program that provides unique learning opportunities
More informationImproving Safety Practices Anticoagulation Therapy
Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and
More informationNursing Dosage Calculations Conversions Practice
Conversions Practice Free PDF ebook Download: Conversions Practice Download or Read Online ebook nursing dosage calculations conversions practice in PDF Format From The Best User Guide Database NURSING
More informationAnatomy of a Fatal Medication Error
Anatomy of a Fatal Medication Error Pamela A. Brown, RN, CCRN, PhD Nurse Manager Pediatric Intensive Care Unit Doernbecher Children s Hospital Objectives Discuss the components of a root cause analysis
More informationPractice Spotlight. Children's Hospital Central California Madera, California
Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW
More informationIMPACT OF TECHNOLOGY ON MEDICATION SAFETY
Continuous Quality Improvement IMPACT OF Steven R. Abel, PharmD, FASHP TECHNOLOGY ON Nital Patel, PharmD. MBA MEDICATION SAFETY Sheri Helms, PharmD Candidate Brian Heckman, PharmD Candidate Ismaila D Badjie
More informationCOURSE INFORMATION FORM
DATE SUBMITTED 6/24/13 CATALOG NO. PNUR 136 DATE DICC APPROVED 9/24/2013 DATE LAST REVIEWED 8/25/2009 DISCIPLINE COURSE TITLE COURSE INFORMATION FORM Practical Nursing Venous Access and Intravenous Infusion
More informationSARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY TITLE: NURSING AND PHARMACY GUIDELINES FOR THE ADMINISTRATION OF IV EPOPROSTENOL (FLOLAN, VELETRI ) POLICY #: EFFECTIVE DATE: REVISED DATE: POLICY
More informationAdverse Drug Events: A Collaborative Approach for Improvement. Mary Kathryn Cone, PGY-2
Adverse Drug Events: A Collaborative Approach for Improvement Mary Kathryn Cone, PGY-2 Background Adverse drug events are far more common than any hospital employee or patient would like to think. Thankfully,
More informationSharp HealthCare Safety Training 2015 Module 3, Lesson 2 Always Events: Line and Tube Reconciliation and Guardrails Use
Sharp HealthCare Safety Training 2015 Module 3, Lesson 2 Always Events: Line and Tube Reconciliation and Guardrails Use Our vision is to create a culture where patients and those who care for them are
More informationThe Institute of Medicine concluded that medical
Hosp Pharm 2015;50(2):113 117 2015 Thomas Land Publishers, Inc. www.hospital-pharmacy.com doi: 10.1310/hpj5002-113 Original Article Optimizing Smart Pump Technology by Increasing Critical Safety Alerts
More informationTo describe the process for the management of an infusion pump involved in an adverse event or close call.
TITLE INFUSION PUMPS FOR MEDICATION & PARENTERAL FLUID ADMINISTRATION SCOPE Provincial, Clinical DOCUMENT # PS-70-01 APPROVAL LEVEL Executive Leadership Team SPONSOR Provincial Medication Management Committee
More informationSafetyFirst Alert. Improving Prescription/Order Writing. Illegible handwriting
SafetyFirst Alert Massachusetts Coalition for the Prevention of Medical Errors January 2000 This issue of Safety First Alert is a publication of the Massachusetts Coalition for the Prevention of Medical
More informationPATIENT CARE MANUAL PROCEDURE
PATIENT CARE MANUAL PROCEDURE NUMBER III-130 PAGE 1 OF 5 APPROVED BY: CATEGORY: Vice President and Senior Operating Officer, Rural Health Services & Professional Practice Lead Medication Administration
More informationIV Interoperability: Smart Pump and BCMA Integration
IV Interoperability: Smart Pump and BCMA Integration Amanda Prusch, PharmD, BCPS Medication Safety Specialist Tina Suess, RN, BSN System Administrator October 5, 2010 Lancaster General Hospital Profile
More informationPatient Safety and Quality Measures for CRRT: The UAB Experience. Ashita Tolwani, M.D. University of Alabama at Birmingham CRRT 2012
Patient Safety and Quality Measures for CRRT: The UAB Experience Ashita Tolwani, M.D. University of Alabama at Birmingham CRRT 2012 Quality Healthcare Quality is the extent to which health services for
More informationPharmacy Department Orientation
Pharmacy Department Orientation June 26, 2015 Brittany N. White, PharmD, BCPS Pharmacy Ext. 7238 Main Pharmacy Department Located on the 6 th floor Open 24 hours a day 7 days a week Children s Located
More informationParenteral Nutrition Drug Shortages
Parenteral Nutrition Drug Shortages Deborah R. Houston, BS, Pharm.D, BCNSP A.S.P.E.N. Clinical Practice Committee Member Pharmacy Clinical Program Coordinator Advanced Home Care High Point, North Carolina
More informationReducing Medical Errors at the Bedside
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/reducing-medical-errors-at-the-bedside/3974/
More informationPROCESS FOR HANDLING ELASTOMERIC PAIN RELIEF BALLS (ON-Q PAINBUSTER AND OTHERS)
PROCESS FOR HANDLING ELASTOMERIC PAIN RELIEF BALLS (ON-Q PAINBUSTER AND OTHERS) REQUIRES SAFETY IMPROVEMENTS From the July 16, 2009 issue Problem: In our May 21, 2009, newsletter we noted an association
More informationPGY-1 Pharmacy Practice
Lutheran Health Network PGY-1 Pharmacy Practice Residency Program LHN Pharmacy Residency Program Mission Statement The mission of the LHN Pharmacy Residency Program is to empower pharmacy residents to
More informationPediatric Math. Review of formulas: On hand: vehicle:: desired dose : x CONVERTING POUNDS TO KILOGRAMS: 2.2 pounds (lb) = 1kilogram (kg)
Pediatric Math Children are more susceptible to medications than adults due to immature systems, metabolism and physical composition that can alter the pharmacokinetics of drugs. Therefore it is essential
More informationAutomation and Information Technology
4 Automation and Information Technology Positions Automation and Information Technology Ensuring Patient Safety and Data Integrity During Cyber-attacks (1701) To advocate that healthcare organizations
More informationINQUEST INTO THE DEATH OF: MARIE TANNER
INQUEST INTO THE DEATH OF: MARIE TANNER Details Name of Deceased: Marie Tanner Date of Death: January 21, 2002 Place of Death: Peterborough Regional Health Centre Cause of Death: Cardiac Arrest Caused
More informationEncouraging pharmacy involvement in pharmacovigilance; an international perspective.
Encouraging pharmacy involvement in pharmacovigilance; an international perspective. Michael R. Cohen, RPh, MS, ScD (hon) DPS (hon) Chairperson, International Medication Safety Network and President, Institute
More informationSARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY
PS1006 SARASOTA MEMORIAL HOSPITAL NURSING DEPARTMENT POLICY TITLE: NURSING AND PHARMACY GUIDELINES FOR THE ADMINISTRATION OF IV TREPROSTINIL (REMODULIN ) Job Title of Reviewer: Director, Pharmacy POLICY
More informationThe Colorado ALTO Project
Using Alternatives to Opioids (ALTOs) in Hospital Emergency Departments PRE-LAUNCH CHECKLIST Based on the 2017 Opioid Prescribing & Treatment Guidelines Colorado ALTO Project Champion Sets the direction
More informationGiving Intravenous (IV) Nutrition Through a Central Line with a CADD Pump
Home Care Services Giving Intravenous (IV) Nutrition Through a Central Line with a CADD Pump Receiving medicine and supplies When you receive a shipment, make sure you have the correct medicine and supplies.
More informationU: Medication Administration
U: Medication Administration Alberta Licensed Practical Nurses Competency Profile 199 Competency: U-1 Pharmacology and Principles of Administration of Medications U-1-1 U-1-2 U-1-3 U-1-4 Demonstrate knowledge
More informationWYOMING STATE BOARD OF NURSING ADVISORY OPINION INTRAVENOUS THERAPY BY LICENSED PRACTICAL NURSES
WYOMING STATE BOARD OF NURSING ADVISORY OPINION INTRAVENOUS THERAPY BY LICENSED PRACTICAL NURSES Advisory Opinion Number: 03-123 Board Meeting Date: April 28-May 1, 2003 January 7-10, 2008 February 18,
More informationObjective Competency Competency Measure To Do List
2016 University of Washington School of Pharmacy Institutional IPPE Checklist Institutional IPPE Team Contact Info: Kelsey Brantner e-mail: ippe@uw.edu phone: 206-543-9427; Jennifer Danielson, PharmD e-mail:
More information201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice.
201 KAR 20:490. Licensed practical nurse intravenous therapy scope of practice. RELATES TO: KRS 314.011(10)(a), (c) STATUTORY AUTHORITY: KRS 314.011(10)(c), 314.131(1), 314.011(10)(c) NECESSITY, FUNCTION,
More information2017 Pharmacy Education Series
2017 Pharmacy Education Series March 15, 2017 2017 Joint Commission Update Featured Speakers: Patricia C. Kienle, RPh, MPA, FASHP Terry Baughman Kathryn E. DeSear, PharmD, BCPS, AAHIVP Online Evaluation,
More informationDepartment of Interdisciplinary Studies. IDST 1400 Medical Mathematics Revised 2015 by: Marilyn Donahue
Department of Interdisciplinary Studies IDST 1400 Medical Mathematics Revised 2015 by: Marilyn Donahue Course Description This course will provide a review of basic mathematical calculations and will instruct
More informationTo prevent harm to patients from adverse medication events involving high-alert medications.
TITLE MANAGEMENT OF HIGH-ALERT MEDICATIONS DOCUMENT # PS-46-01 PARENT DOCUMENT LEVEL LEVEL 1 PARENT DOCUMENT TITLE Management of High-alert Medications Policy APPROVAL LEVEL Alberta Health Services Executive
More informationMedication Errors An Opportunity to Improve
FSHP Medication Errors An Opportunity to Improve Laura Monroe-Duprey, BS Pharm, PharmD Joanie Spiro Stevens, PharmD, BCPS Disclosure Laura Monroe-Duprey - I do not have (nor does any immediate family member
More informationPOLICY. Clinician is any health care professional accepting responsibility for care of patients and their medications.
POLICY Number: 7311-60-020 Title: HIGH ALERT MEDICATIONS IDENTIFICATION, DOUBLE CHECK AND LABELING Authorization [ ] President and CEO [X ] Vice President, Finance and Corporate Services Source: Chair,
More informationwith the team that understands your drug delivery needs. Comprehensive solutions in drug delivery.
with the team that understands your drug delivery needs. Comprehensive solutions in drug delivery. Solutions that can meet your needs. COMPLIANCE Patient Care As IV therapy becomes more sophisticated and
More informationMedication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety
Medication Safety Action Bundle Adverse Drug Events (ADE) All High-Risk Medication Safety Background The Institute of medicine (IOM) estimates that 1.5 million preventable Adverse Drug Events (ADE) occur
More informationMedication Use Evaluation and Cost Minimization Analysis of Injectable Nicardipine in a Community Hospital
Medication Use Evaluation and Cost Minimization Analysis of Injectable Nicardipine in a Community Hospital Christopher Brown, PharmD PGY-1 Pharmacy Resident Norman Regional Health System April 8, 2016
More informationHospital Self Assessment Worksheet
DESCRIPTION AND INSTRUCTIONS This worksheet consists of 106 questions assessing adoption of the Hospital Self- Assessment recommendations at the hospital level. These recommendations were based on the
More informationLittle People, Big Drugs: Pediatric Medication Safety in Adult Settings. Pediatric Hospital Medicine Conference July 23, 2017.
Little People, Big Drugs: Pediatric Medication Safety in Adult Settings Pediatric Hospital Medicine Conference July 23, 2017 Francisco Alvarez, MD, FAAP Lana Ismail, MD, FAAP Allison Markowsky, MD, FAAP
More informationLUNCH AND LEARN. June 9, CE Activity Information & Accreditation
LUNCH AND LEARN Joint Commission Update 2017 June 9, 2017 Featured Speaker: Kurt A. Patton, MS, RPh President Emeritus Patton Healthcare Consulting, LLC CE Activity Information & Accreditation (Pharmacist
More informationUse of Automation and Robotic Technology to Improve the Process for Preparing Compounded Sterile Products
Use of Automation and Robotic Technology to Improve the Process for Preparing Compounded Sterile Products Presented as a Live Webinar Monday, October 25, 2010 Planned and conducted by ASHP Advantage and
More informationSmart Pumps and Drug Libraries The Way Forward
Smart Pumps and Drug Libraries The Way Forward Kathryn Phillips North West Regional MI Centre The first stop for professional medicines advice Outline The drivers behind the development/use of Smart Pumps
More informationMedication Calculation Practice Problems LEVEL II, III and IV 1. The order reads for digoxin mg IM daily. Available to the nurse is digoxin
Medication Calculation Practice Problems LEVEL II, III and IV 1. The order reads for digoxin 0.125 mg IM daily. Available to the nurse is digoxin 0.25 mg/ml. The nurse would administer how many ml s? 2.
More informationPediatric Emergencies and Resuscitation. Color Coding Kids to optimize patient safety
Pediatric Emergencies and Resuscitation Color Coding Kids to optimize patient safety Susan Hohenhaus, RN Project Manager Duke University Medical Center Department of Pediatric Emergency Medicine EMSC Enhancing
More informationFundamentals of IV Micronutrient Therapy And Clinical Applications of Parenteral Products Seminar
Fundamentals of IV Micronutrient Therapy And Clinical Applications of Parenteral Products Seminar Presented by: Intravenous Nutritional Therapy for Physicians and McGuff Company What: Fundamentals of IV
More informationNOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.
TITLE MEDICATION ORDERS SCOPE Provincial APPROVAL AUTHORITY Clinical Operations Executive Committee SPONSOR Provincial Medication Management Committee PARENT DOCUMENT TITLE, TYPE AND NUMBER Medication
More informationMost of you flew to this meeting
Most of you flew to this meeting on an airplane and, like me, ignored the flight attendant asking you to pay attention and listen to a few safety warnings that were being offered. In spite of having listened,
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:
More informationUSP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD
USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL ACTIVITY DESCRIPTION On June 1, 2008, The Revision Bulletin to USP Chapter 797, Pharmaceutical
More informationIntroducing ISMP s New Targeted Best Practices for
Introducing ISMP s New Targeted Best Practices for 2018-2019 Darryl S. Rich, PharmD, MBA, FASHP Medication Safety Specialist Institute for Safe Medication Practices (ISMP) Horsham, PA 1 Disclosure The
More information4/26/2017. Emergency Department Pharmacist Interventions in a Small, Rural Hospital. Disclosure Statement. Learning Objectives
Emergency Department Pharmacist Interventions in a Small, Rural Hospital Chaundra Sewell, PharmD PGY1 Pharmacy Practice Resident Community Medical Center Missoula, MT Disclosure Statement This presenter
More informationSmart Pump Interoperability: A Multi-System Safety Journey. February 23, 2018
Smart Pump Interoperability: A Multi-System Safety Journey February 23, 2018 Jennifer Biltoft, PharmD, BCPS System Director, Clinical Pharmacy Services, SCL Health Deborah Bonnes, RN, MS Nursing Informatics
More informationHow CHRISTUS Spohn Health System uses automation to improve standardization and re-deploy pharmacists to clinical functions
A culture of medication safety: How CHRISTUS Spohn Health System uses automation to improve standardization and re-deploy pharmacists to clinical functions Authored and produced by CareFusion, August 2013
More informationRaising the Bar On Infusion Safety: A Patient Safety Program at Baylor Scott & White Health Improving Infusion Pump Safety: A Systematic Approach
Raising the Bar On Infusion Safety: A Patient Safety Program at Baylor Scott & White Health Improving Infusion Pump Safety: A Systematic Approach July 18, 2016 AAMI Foundation Vision: To drive the safe
More informationThis document is NOT FOR PROMOTIONAL USE. Do not copy, distribute, or share with physicians, staff, or patients. FOR INTERNAL USE ONLY.
SIMPONI ARIA Infusion Suite Module Summary Page 1 of 5 The trademark, SIMPONI ARIA, has received provisional acceptance from the FDA. SIMPONI ARIA is an investigational agent currently under review by
More informationMedical Assistant Drug Calculations Practice
Drug Practice Free PDF ebook Download: Practice Download or Read Online ebook medical assistant drug calculations practice in PDF Format From The Best User Guide Database Registered (RMA) Practice Exams
More information